Nosokomycin B
| Internal ID | d7e14a8b-762e-47bd-b368-b77a60d8bf9c |
| Taxonomy | Lipids and lipid-like molecules > Prenol lipids > Terpene glycosides |
| IUPAC Name | (2R)-3-[[(2R,3R,4R,5S,6S)-3-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2S,3R,4R,5S,6R)-3-acetamido-5-[(2R,3R,4S,5S,6S)-6-carbamoyl-3,4,5-trihydroxyoxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-[[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxymethyl]oxan-2-yl]oxy-6-carbamoyl-4-carbamoyloxy-5-hydroxy-5-methyloxan-2-yl]oxy-hydroxyphosphoryl]oxy-2-[(2Z,5E,13E)-3,8,8,14,18-pentamethyl-11-methylidenenonadeca-2,5,13,17-tetraenoxy]propanoic acid |
| SMILES (Canonical) | CC1C(C(C(C(O1)OC2C(OC(C(C2O)NC(=O)C)OC3C(C(C(OC3OP(=O)(O)OCC(C(=O)O)OCC=C(C)CC=CCC(C)(C)CCC(=C)CC=C(C)CCC=C(C)C)C(=O)N)(C)O)OC(=O)N)COC4C(C(C(C(O4)CO)O)O)O)NC(=O)C)O)OC5C(C(C(C(O5)C(=O)N)O)O)O |
| SMILES (Isomeric) | C[C@@H]1[C@H]([C@@H]([C@H]([C@@H](O1)O[C@@H]2[C@H](O[C@H]([C@@H]([C@H]2O)NC(=O)C)O[C@@H]3[C@H]([C@]([C@H](O[C@@H]3OP(=O)(O)OC[C@H](C(=O)O)OC/C=C(/C)\C/C=C/CC(C)(C)CCC(=C)C/C=C(\C)/CCC=C(C)C)C(=O)N)(C)O)OC(=O)N)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O)O)O)NC(=O)C)O)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)C(=O)N)O)O)O |
| InChI | InChI=1S/C64H104N5O32P/c1-28(2)15-14-17-29(3)18-19-31(5)20-23-63(9,10)22-13-12-16-30(4)21-24-89-37(56(83)84)27-91-102(87,88)101-61-51(52(100-62(67)85)64(11,86)53(99-61)55(66)82)98-58-39(69-34(8)72)42(75)49(36(94-58)26-90-59-46(79)43(76)40(73)35(25-70)93-59)96-57-38(68-33(7)71)41(74)48(32(6)92-57)95-60-47(80)44(77)45(78)50(97-60)54(65)81/h12-13,15,18,21,32,35-53,57-61,70,73-80,86H,5,14,16-17,19-20,22-27H2,1-4,6-11H3,(H2,65,81)(H2,66,82)(H2,67,85)(H,68,71)(H,69,72)(H,83,84)(H,87,88)/b13-12+,29-18+,30-21-/t32-,35-,36-,37-,38-,39-,40-,41-,42-,43+,44+,45+,46-,47-,48-,49-,50+,51-,52-,53-,57+,58+,59-,60-,61-,64+/m1/s1 |
| InChI Key | TYUZCHWUMDBFJO-OQDLKAIYSA-N |
| Popularity | 0 references in papers |
| Molecular Formula | C64H104N5O32P |
| Molecular Weight | 1486.50 g/mol |
| Exact Mass | 1485.6402032 g/mol |
| Topological Polar Surface Area (TPSA) | 584.00 Ų |
| XlogP | -1.50 |
| Atomic LogP (AlogP) | -2.79 |
| H-Bond Acceptor | 30 |
| H-Bond Donor | 17 |
| Rotatable Bonds | 36 |
| There are no found synonyms. |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | - | 0.7507 | 75.07% |
| Caco-2 | - | 0.8582 | 85.82% |
| Blood Brain Barrier | - | 0.7750 | 77.50% |
| Human oral bioavailability | - | 0.8143 | 81.43% |
| Subcellular localzation | Mitochondria | 0.6635 | 66.35% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8002 | 80.02% |
| OATP1B3 inhibitior | + | 0.9277 | 92.77% |
| MATE1 inhibitior | - | 0.9800 | 98.00% |
| OCT2 inhibitior | - | 0.8526 | 85.26% |
| BSEP inhibitior | + | 0.9399 | 93.99% |
| P-glycoprotein inhibitior | + | 0.7423 | 74.23% |
| P-glycoprotein substrate | + | 0.8174 | 81.74% |
| CYP3A4 substrate | + | 0.7548 | 75.48% |
| CYP2C9 substrate | - | 1.0000 | 100.00% |
| CYP2D6 substrate | - | 0.8627 | 86.27% |
| CYP3A4 inhibition | - | 0.6137 | 61.37% |
| CYP2C9 inhibition | - | 0.7721 | 77.21% |
| CYP2C19 inhibition | - | 0.7299 | 72.99% |
| CYP2D6 inhibition | - | 0.8853 | 88.53% |
| CYP1A2 inhibition | - | 0.7800 | 78.00% |
| CYP2C8 inhibition | + | 0.8263 | 82.63% |
| CYP inhibitory promiscuity | - | 0.8989 | 89.89% |
| UGT catelyzed | - | 0.5000 | 50.00% |
| Carcinogenicity (binary) | - | 0.9000 | 90.00% |
| Carcinogenicity (trinary) | Non-required | 0.5240 | 52.40% |
| Eye corrosion | - | 0.9780 | 97.80% |
| Eye irritation | - | 0.8959 | 89.59% |
| Skin irritation | - | 0.7535 | 75.35% |
| Skin corrosion | - | 0.9139 | 91.39% |
| Ames mutagenesis | + | 0.5346 | 53.46% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7308 | 73.08% |
| Micronuclear | + | 0.7700 | 77.00% |
| Hepatotoxicity | - | 0.5825 | 58.25% |
| skin sensitisation | - | 0.8219 | 82.19% |
| Respiratory toxicity | + | 0.7111 | 71.11% |
| Reproductive toxicity | + | 0.8111 | 81.11% |
| Mitochondrial toxicity | + | 0.8625 | 86.25% |
| Nephrotoxicity | - | 0.7289 | 72.89% |
| Acute Oral Toxicity (c) | III | 0.5902 | 59.02% |
| Estrogen receptor binding | - | 0.4754 | 47.54% |
| Androgen receptor binding | + | 0.7388 | 73.88% |
| Thyroid receptor binding | + | 0.7432 | 74.32% |
| Glucocorticoid receptor binding | + | 0.8165 | 81.65% |
| Aromatase binding | + | 0.7504 | 75.04% |
| PPAR gamma | + | 0.8106 | 81.06% |
| Honey bee toxicity | - | 0.5754 | 57.54% |
| Biodegradation | - | 0.8250 | 82.50% |
| Crustacea aquatic toxicity | - | 0.5400 | 54.00% |
| Fish aquatic toxicity | + | 0.9828 | 98.28% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 98.91% | 91.11% |
| CHEMBL1293294 | P51151 | Ras-related protein Rab-9A | 98.88% | 87.67% |
| CHEMBL4261 | Q16665 | Hypoxia-inducible factor 1 alpha | 96.79% | 85.14% |
| CHEMBL1293277 | O15118 | Niemann-Pick C1 protein | 96.39% | 81.11% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 96.19% | 97.29% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 95.43% | 96.09% |
| CHEMBL3401 | O75469 | Pregnane X receptor | 95.30% | 94.73% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 94.71% | 97.25% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 94.22% | 99.17% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 93.95% | 96.47% |
| CHEMBL2581 | P07339 | Cathepsin D | 93.70% | 98.95% |
| CHEMBL233 | P35372 | Mu opioid receptor | 92.58% | 97.93% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 92.39% | 96.00% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 91.63% | 91.19% |
| CHEMBL2413 | P32246 | C-C chemokine receptor type 1 | 91.53% | 89.50% |
| CHEMBL1293267 | Q9HC97 | G-protein coupled receptor 35 | 90.68% | 89.34% |
| CHEMBL218 | P21554 | Cannabinoid CB1 receptor | 89.90% | 96.61% |
| CHEMBL3714130 | P46095 | G-protein coupled receptor 6 | 89.34% | 97.36% |
| CHEMBL6136 | O60341 | Lysine-specific histone demethylase 1 | 87.96% | 95.58% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 87.52% | 91.24% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 87.47% | 96.90% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.24% | 94.33% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 86.86% | 93.56% |
| CHEMBL1806 | P11388 | DNA topoisomerase II alpha | 86.37% | 89.00% |
| CHEMBL3880 | P07900 | Heat shock protein HSP 90-alpha | 85.09% | 96.21% |
| CHEMBL1293316 | Q9HBX9 | Relaxin receptor 1 | 84.99% | 82.50% |
| CHEMBL3976 | Q9UHL4 | Dipeptidyl peptidase II | 83.94% | 92.29% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 83.86% | 95.83% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 83.78% | 94.00% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 83.08% | 94.45% |
| CHEMBL4581 | P52732 | Kinesin-like protein 1 | 82.92% | 93.18% |
| CHEMBL3038477 | P67870 | Casein kinase II alpha/beta | 82.66% | 99.23% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 82.63% | 100.00% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 81.98% | 97.47% |
| CHEMBL4662 | P28074 | Proteasome Macropain subunit MB1 | 81.80% | 93.85% |
| CHEMBL2474 | P53582 | Methionine aminopeptidase 1 | 81.76% | 97.09% |
| CHEMBL5255 | O00206 | Toll-like receptor 4 | 81.73% | 92.50% |
| CHEMBL2842 | P42345 | Serine/threonine-protein kinase mTOR | 81.71% | 92.78% |
| CHEMBL2072 | P35499 | Sodium channel protein type IV alpha subunit | 81.61% | 92.32% |
| CHEMBL4015 | P41597 | C-C chemokine receptor type 2 | 81.53% | 98.57% |
| CHEMBL3286 | P00749 | Urokinase-type plasminogen activator | 81.00% | 97.88% |
| CHEMBL2001 | Q9H244 | Purinergic receptor P2Y12 | 80.85% | 96.00% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 80.72% | 95.50% |
| CHEMBL5028 | O14672 | ADAM10 | 80.14% | 97.50% |
| CHEMBL279 | P35968 | Vascular endothelial growth factor receptor 2 | 80.12% | 95.52% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 102041021 |
| LOTUS | LTS0109887 |
| wikiData | Q105267747 |